Abstract:The molecular mechanisms underlying fetal growth restriction (FGR) remain poorly understood. We investigated a role for H19, a long noncoding RNA (lncRNA) that is highly expressed in placenta, in the pathogenesis of FGR. We used RT-qPCR to compare levels of H19 in placentas from pregnancies with idiopathic preterm FGR (n = 12) and gestational age-matched controls with spontaneous preterm delivery (n = 12). We then used siRNA-mediated H19 knockdown on first trimester extravillous trophoblast (EVT) cells to evaluate the effect of decreased H19 on cell function, via trans-well migration and invasion studies. Subsequently, we performed genome-scale transcriptome profiling, coupled with pathway analysis, to determine a mechanism for our observed changes. Parametric and nonparametric statistical analysis was performed as appropriate, with significance set at a p value of <0.05. H19 level is approximately 2-fold lower in placentas with FGR as compared to controls (p=0.02). H19 knockdown in EVT cells leads to impaired migration (p=0.02) and invasion (p<0.01). Genome-scale transcriptome profiling and pathway analysis reveal decreased expression of betaglycan (TGFβ type III receptor), a direct regulator of ligand access to the TGFβ signaling receptors, in both H19 knockdown EVT cells (p<0.01) and FGR placentas (p=0.01). Additionally, the increased bioavailability of microRNA let-7, as a result of decreased H19, contributes to reduced expression of betaglycan, a novel target of let-7-mediated posttranscriptional regulation. Depressed H19 level leads to impaired migration and invasion of a human trophoblast cell line, consistent with failure of trophoblast invasion associated with FGR. Dysregulation of this newly identified H19/TGFβ signaling regulatory pathway may contribute to the underlying molecular mechanism of idiopathic FGR. Our finding represents the first example of a lncRNA-based mechanism in FGR, thus holding promise in the development of novel diagnostic and therapeutic modalities for this detrimental disorder.

IL-27 Deficiency Inhibits Proliferation and Invasion of Trophoblasts Via the SFRP2/Wnt/β-catenin Pathway in Fetal Growth Restriction.

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

Decreased PGF May Contribute to Trophoblast Dysfunction in Fetal Growth Restriction.

Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System

Gestational Exposure to PM2.5 Disrupts Fetal Development by Suppressing Placental Trophoblast Syncytialization Via Progranulin/mtor Signaling.

161: H19 Lncrna Alters Trophoblast Cell Migration and Invasion Through TGF-β Signaling in Placentas with Fetal Growth Restriction

CircTHBS1 Promotes Trophoblast Cell Migration and Invasion and Inhibits Trophoblast Apoptosis by Regulating Mir-136-3p/igf2r Axis

Dysfunction of Tregs Contributes to FGR Pathogenesis Via Regulating Smads Signalling Pathway.

The placental blood perfusion and LINC00473-mediated promotion of trophoblast apoptosis in fetal growth restriction

miR-1227-3p participates in the development of fetal growth restriction via regulating trophoblast cell proliferation and apoptosis

Emerging Roles of IL‐27 in Trophoblast Cells and Pregnancy Complications

Gdf8 Promotes The Cell Invasiveness In Human Trophoblasts By Upregulating The Expression Of Follistatin-Like 3 Through The Alk5-Smad2/3 Signaling Pathway

Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction

The Placental NLRP3 Inflammasome and Its Downstream Targets, Caspase-1 and Interleukin-6, Are Increased in Human Fetal Growth Restriction: Implications for Aberrant Inflammation-Induced Trophoblast Dysfunction

An miRNA-mRNA integrative analysis in human placentas and mice: role of the Smad2/miR-155-5p axis in the development of fetal growth restriction

Progress in the understanding of the etiology and predictability of fetal growth restriction

Mir-181D-5p, Which is Upregulated in Fetal Growth Restriction Placentas, Inhibits Trophoblast Fusion Via CREBRF.

Usp22 Regulates The Formation And Function Of Placental Vasculature During The Development Of Fetal Growth Restriction

FGR-associated Placental Insufficiency and Capillary Angiogenesis Involves Disruptions in Human Placental Mirnas and Mrnas

Mir-141 Contributes To Fetal Growth Restriction By Regulating Plag1 Expression

Fetal growth restriction induced by maternal gal-3 deficiency is associated with altered gut-placenta axis